Design and preliminary results of a randomized study on the conversion of treatment with calcineurin inhibitors to mycophenolate mofetil in chronic renal graft failure: effect, on serum cholesterol levels.
Suwelack
Barbara
B
Medizinische Poliklinik, Universität Münster, Albert-Schweitzer-Strasse 33, D-48149 Münster, Germany. suwelac@uni-muenster.de
Gerhardt
U
U
Kobelt
V
V
Hillebrand
U
U
Matzkies
F
F
Hohage
H
H
D019703:Calcineurin / Q000009:adverse effects*; D065095:Calcineurin Inhibitors; D002784:Cholesterol / Q000097:blood*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000473:pathology / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012107:Research Design; D013997:Time Factors; D017211:Treatment Failure
D065095:Calcineurin Inhibitors; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D002784:Cholesterol; D007168:IMP Dehydrogenase; D019703:Calcineurin; D009173:Mycophenolic Acid